Validity and Reliability of Turkish Version Leg Activity Measure
NCT ID: NCT05182411
Last Updated: 2022-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2022-06-30
2022-08-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therefore, Leg activity measure, a new self-report measure of active and passive function in the leg, has been developed.
Leg activity measure consists of three parts. The first part includes passive functions, the second part includes active functions, and the third part includes the assessment of quality of life.
It is a valid and reliable test in adult neurological patients with lower extremity spasticity. It can be used in the evaluation of the active and passive functions of the results of the clinicians' interventions by making the cultural adaptation of the Turkish language and examining its validity and reliability. We think that it will be important to determine the limitations in activity, participation and daily living activities and to evaluate their reflections.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Turkish Lower-Extremity Motor Activity Log (LE-MAL)
NCT06156813
Gait Analysis in Multiple Sclerosis Patients
NCT05299151
Validity and Reliability of the 2-minute Step Test in Patients With Lumbar Spinal Stenosis
NCT06060821
Validity and Reliability of Lower Extremity Position Test in Patients with Multiple Sclerosis
NCT05663541
The Relationship Between Fatigue and Physical Activity Level in Patients With Multiple Sclerosis
NCT03255460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Goals for the treatment of spasticity often focus on active function improvements in walking, standing, and moving from different sitting positions. However, improvements in passive function tasks and symptom management are often equally important to patients. Active function is the use of the limb to directly perform a task. Passive fonskyion is care of the affected extremity, usually performed by the person himself, but may require assistance from another person.
There is a need for instruments with demonstrable measurement properties that can reflect a clinically significant change in practice. Outcomes developed for treatments such as botulinum toxin and physical interventions for spasticity aimed at improving any aspect of functional performance (active and passive function) should ideally reflect real-life function as opposed to simply observed tasks in the clinical setting.
Leg activity measure filled by the patient consists of three parts. The first part includes passive functions, the second part includes active functions, and the third part includes the assessment of quality of life.
It is a valid and reliable test in adult neurological patients with lower extremity spasticity. It can be used in the evaluation of the active and passive functions of the results of the clinicians' interventions by making the cultural adaptation of the Turkish language and examining its validity and reliability.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with spasticity
adult neurological patients with spasticities in their lower extremities
assessment
Turkish version of Leg Activity Measure Rivearmead Mobility Index Nottingham Health Profile Functional Independence Measures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
assessment
Turkish version of Leg Activity Measure Rivearmead Mobility Index Nottingham Health Profile Functional Independence Measures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be between the ages of 18-65
* Volunteering to participate in the study
Exclusion Criteria
* History of trauma in the last 1 year
* Having alcohol and substance abuse
* Having a pregnancy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zekiye İpek KATIRCI KIRMACI
Asst. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zekiye İpek Katırcı Kırmacı
Role: PRINCIPAL_INVESTIGATOR
Kahramanmaras Sutcu Imam University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kahramanmaraş Sutcu Imam University
Kahramanmaraş, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kirmaci ZIK, Adiguzel H, Kirmaci YS, Tasvuran Horata E, Tuncel Berktas D, Erel S. Turkish translation and transcultural validity and reliability of an assessment tool for spasticity: Leg Activity Measure (Leg A). Neurol Res. 2024 Jul;46(7):644-652. doi: 10.1080/01616412.2024.2340878. Epub 2024 May 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ipekkkirmaci
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.